When can a salvage therapy (T-DM1) take the lead?

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)3492-3494
Number of pages3
JournalJournal of Clinical Oncology
Volume34
Issue number29
DOIs
StatePublished - Oct 10 2016

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

When can a salvage therapy (T-DM1) take the lead? / Mahtani, Reshma; Vogel, Charles.

In: Journal of Clinical Oncology, Vol. 34, No. 29, 10.10.2016, p. 3492-3494.

Research output: Contribution to journalEditorial

@article{3d50178f85c6441f8dac89fc0864e544,
title = "When can a salvage therapy (T-DM1) take the lead?",
author = "Reshma Mahtani and Charles Vogel",
year = "2016",
month = "10",
day = "10",
doi = "10.1200/JCO.2016.68.4241",
language = "English (US)",
volume = "34",
pages = "3492--3494",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "29",

}

TY - JOUR

T1 - When can a salvage therapy (T-DM1) take the lead?

AU - Mahtani, Reshma

AU - Vogel, Charles

PY - 2016/10/10

Y1 - 2016/10/10

UR - http://www.scopus.com/inward/record.url?scp=84990062802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990062802&partnerID=8YFLogxK

U2 - 10.1200/JCO.2016.68.4241

DO - 10.1200/JCO.2016.68.4241

M3 - Editorial

C2 - 27432926

AN - SCOPUS:84990062802

VL - 34

SP - 3492

EP - 3494

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 29

ER -